Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Shares Issued (2016 - 2025)

Mimedx's Shares Issued history spans 14 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 761.41% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, changed 0.19%, while the annual FY2025 figure was $1.6 million, 0.19% changed from the prior year.
  • Shares Issued for Q4 2025 was $1.6 million at Mimedx, up from -$848000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.6 million in Q4 2025 and bottomed at -$1.4 million in Q4 2021.
  • The 4-year median for Shares Issued is $522500.0 (2021), against an average of $345428.6.
  • The largest annual shift saw Shares Issued tumbled 4780.0% in 2021 before it surged 2635.48% in 2025.
  • A 4-year view of Shares Issued shows it stood at -$1.4 million in 2021, then surged by 168.45% to $961000.0 in 2023, then plummeted by 80.85% to $184000.0 in 2024, then skyrocketed by 761.41% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Shares Issued are $1.6 million (Q4 2025), -$848000.0 (Q3 2025), and $848000.0 (Q2 2025).